troglitazone has been researched along with Mouth Neoplasms in 3 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, M | 1 |
| Fujita, Y | 1 |
| Kuribayashi, N | 1 |
| Uchida, D | 2 |
| Komiyama, Y | 1 |
| Fukumoto, C | 1 |
| Hasegawa, T | 1 |
| Kawamata, H | 2 |
| Nakashiro, K | 1 |
| Begum, NM | 1 |
| Shintani, S | 1 |
| Sato, M | 1 |
| Hamakawa, H | 1 |
| Fukuchi, K | 1 |
| Date, M | 1 |
| Azuma, Y | 1 |
| Shinohara, M | 1 |
| Takahashi, H | 1 |
| Ohura, K | 1 |
3 other studies available for troglitazone and Mouth Neoplasms
| Article | Year |
|---|---|
Troglitazone, a Selective Ligand for PPARĪ³, Induces Cell-cycle Arrest in Human Oral SCC Cells.
Topics: Cell Cycle Checkpoints; Cell Growth Processes; Humans; Hypoglycemic Agents; Ligands; Mouth Neoplasms | 2020 |
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Chromans; DNA Mutational Analysis; Humans; Mouth Neoplas | 2003 |
Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone.
Topics: Amino Acid Chloromethyl Ketones; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, | 2003 |